10Y annualized return is
very good
at 12.6% per year
EW has met or exceeded earnings expectations in
the majority of
recent quarters (8/10)
Low PE Ratio
High Gross Profit Margin
High Price-to-Sales Ratio
High EV/EBITDA Ratio
Get access to all key takeaways, detailed financial metrics, and comprehensive stock analysis with our premium subscription.
Already have an account? Sign in
Overall, Edwards demonstrates a strong business model with a competitive edge in the structural heart market, bolstered by a diversified product portfolio and solid financial health. However, challenges in TAVR growth and short-term guidance indicate potential market pressures. Future prospects are promising, especially with TMTT growth and upcoming regulatory approvals, positioning the company well for sustained growth.
Analysis Date: February 11, 2025
Last Updated: May 29, 2025
Past performance does not guarantee future results. The data presented is indicative and may not be updated in real-time.
Edwards Lifesciences Corporation is a company that makes medical devices to help people with heart problems. They create tools that allow doctors to replace or repair heart valves without needing to perform major surgery. Their products also help monitor patients' heart health, especially in hospitals. Founded in 1958 and based in California, Edwards Lifesciences focuses on improving patient care for those with serious heart conditions.
Streams of revenue
Geographic Distribution
Core Products
Business Type
Business to Business
Competitive Advantages
Discover all competitive advantages and strategic moats that protect EW's market position.
View Premium AnalysisKey Business Risks
Get comprehensive insight into all key business risks that could impact EW's performance.
Access Full Risk AnalysisTrailing Twelve Months (TTM) values provide a view of the company's performance over the last year.
Benjamin Graham's value investing approach focuses on finding stocks with a significant margin of safety between their intrinsic value and market price.
Access Benjamin Graham's value investing criteria, intrinsic value calculations, and margin of safety analysis
Trailing Twelve Months (TTM) values provide a view of the company's performance over the last year.
Profitability metrics measure a company's ability to generate earnings relative to its revenue, operating costs, and other relevant metrics. Higher values generally indicate better performance.
Access detailed profitability metrics with visual gauges and benchmarks
Access detailed analysis of profitability strengths and positive performance indicators
Upgrade to PremiumAccess detailed analysis of profitability weaknesses and areas of concern
Upgrade to PremiumFinancial health metrics assess a company's ability to meet its financial obligations and its overall financial stability.
Access detailed financial health metrics with visual gauges and risk assessments
Access detailed analysis of financial health strengths and stability indicators
Upgrade to PremiumAccess detailed analysis of financial health weaknesses and risk factors
Upgrade to PremiumMeeting Expectations
Higher values indicate better execution and credibility
Recent Results
View complete earnings history and detailed performance analysis
Upgrade to PremiumEPS
Revenue
Insider trading data shows purchase and sale activities by company executives and board members.
Insider trading patterns can provide insights into how company executives and board members view the stock's future prospects.
Get complete insider sentiment analysis with detailed trading patterns, sentiment indicators, and trend insights